CAPA-IVM Culture With Low Oxygen Tension
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Maturation rate
研究概览
简要总结
Capacitation in-vitro maturation (CAPA-IVM) has recently been advanced in culturing oocytes from the germinal vesicle (GV) stage following mild or no controlled ovarian stimulation. Recent research suggested that O2 concentration may significantly regulate oocyte maturation and early embryo development through hypoxia-inducible factor (HIF). Nonetheless, it has been challenging to create the environmental culture conditions for addressing the optimal number of oocytes and the highest possibility of embryo development since consensus on the oxygen (O2) concentration index in the IVM culture environment has not been reached. Based on the outcomes of atmospheric O2 concentration (20%) and low O2 concentration (5%) during CAPA-IVM culture in mice, it has been hypothesized that a 5% O2 was the optimal culture condition for the pre-IVM step. A 20% O2 was more suitable for the IVM culture step. Therefore, this study is designed to enhance the CAPA-IVM culture system, improving treatment efficiency and providing various benefits for patients undergoing assisted reproductive technology.
详细描述
Capacitation in-vitro maturation (CAPA-IVM) has recently been advanced in culturing oocytes from the germinal vesicle (GV) stage. This approach is a modified version of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), following mild stimulation or no controlled ovarian stimulation occurred. Specifically, IVM can be indicated for patients diagnosed with polycystic ovary syndrome (PCOS), a higher number of secondary follicles (constituting nearly 15% of total patients), and treat a range of patients with the risks of ovarian hyperstimulation, venous thromboembolism or ovarian torsion. Additionally, CAPA-IVM helps shorten treatment time, is less expensive, and upgrades patient convenience without multiple follow-up examinations. The live birth rate after the first embryo transfer in the CAPA-IVM group was 35.2%, which was not statistically significantly different from the IVF group at 43.2% (risk difference -8.1%; 95% confidence interval from -16.6% to 0.5%). However, the number of high-quality embryos in each cycle and the cumulative clinical pregnancy rate in CAPA-IVM were still lower than in cIVF.
Moreover, further investigation should be considered due to the lack of high-quality evidence of concurrent reports. Therefore, improving the oocyte maturation conditions in CAPA-IVM to harvest the optimal number of oocytes and the highest possibility of embryo development is essential. Many studies conducted on both animal and human models have demonstrated that the effectiveness of CAPA-IVM depends on various factors. Among these, the environmental culture conditions such as oxygen (O2) concentration play a crucial role in producing healthy mature oocytes. O2 is a vital physical and chemical component of the fallopian tube, uterus and ovarian follicle, it is closely related to metabolic activity, oocyte maturation, and early embryo development. Recent research suggested that O2 concentration may significantly regulate oocyte maturation and early embryo development through hypoxia-inducible factor (HIF). A consensus on the O2 concentration index in the IVM culture environment has not been reached. Oocyte-embedded culture systems have been commonly used in two O2 concentrations, 5% and 20% worldwide. In the human body, cumulus-oocyte complexes (COCs) mature in conditions with low O2 concentrations ranging from 2% to 9%.
Conversely, COCs are exposed to an atmospheric O2 concentration of 20% during IVM manipulation and culture. Although the concentration of 5% mimics the most proper environment in the fallopian tube and uterus, the 20% O2 is widely applied in IVM techniques. The use of high concentrations facilitates a better progression of differentiation processes and increases the maturation rate of oocytes. However, some referential frames indicated that a 20% O2 may pose a risk of reactive oxidative stress (ROS), leading to an imbalance in the ratio of pro-oxidants to antioxidants, resulting in cellular damage. Furthermore, real-time respiration analysis of oocytes cultured at 5% O2 is similar to in vivo-developed oocytes but induced cellular activity and oxygen consumption at 20% O2. The impact of atmospheric O2 concentration (20%) and low O2 concentration (5%) during CAPA-IVM culture in mice shown in the study of Vrije Universiteit Brussel (VUB) - Belgium that the respiratory capability of COCs cultured at 5% O2 was relatively similar to COCs developing and maturing in vivo.
Nonetheless, COCs cultured at 20% O2 increased respiratory activity and oxygen consumption remarkably. The study observed that pre-IVM culture of COCs at 20% O2 caused developmental disruptions. Also, the result was unfavorable if mouse COCs were cultured at the IVM step with 5% O2. Based on these analyses, the researchers hypothesized that a 5% O2 was the optimal culture condition for the pre-IVM step, while a 20% O2 was more relevant to the IVM culture step. Combining these findings with results from VUB and characteristics of the differentiation process in CAPA-IVM oocytes, this study is divided into two main groups, including 5% pre-IVM and 20% IVM versus 20% pre-IVM and IVM) and demonstrates whether this hypothesis should be applied CAPA-IVM in human. The enhancement of the CAPA-IVM culture system leads to improved treatment efficiency of this technique and provides various benefits for patients undergoing assisted reproductive technology.
Study procedure:
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 42 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •18-42 years of age
- •Diagnosed with polycystic ovary syndrome according to the Rotterdam criteria (2003)
- •Indicating CAPA-IVM treatment
- •Having at least 40 antral follicles in two ovaries by transvaginal ultrasound at the time of CAPA-IVM indication
- •Agreeing to have frozen embryo transfer
- •Agreeing to participate in the trial
排除标准
- •Cycles with oocyte donation, preimplantation Genetic Testing (PGT)
- •Couples with severe male factor (sperm concentration <5 million/ml, motility < 10%), surgical sperm retrieval
- •Previous history of unexplained immature oocytes after IVF treatment
- •Uterine abnormalities
结局指标
主要结局
Maturation rate
时间窗: Two day after oocyte retrieval
The oocyte maturation rate was usually defined by MII oocyte number divided by total COCs number
次要结局
- Miscarriage <22 weeks rate (late miscarriage)(At >10 to 20 weeks after the transfer)
- Multiple pregnancy rate(4 weeks after embryo transfer)
- Birth weight(At the time of delivery)
- Number of 2PN oocytes(16-18 hours after ICSI)
- Small for gestational age rate(At birth)
- Large for gestational age rate(At birth)
- Number of patients with no matured oocyte(Two day after oocyte retrieval)
- Fertilization rate(16-18 hours after ICSI)
- Abnormal fertilization rate(16-18 hours after ICSI)
- Number of patients with no day-3 embryo(Five day after oocyte retrieval)
- Total number of oocytes retrieval(On the day of oocyte retrieval)
- Number of GV oocytes(Two day after oocyte retrieval)
- Number of day-3 embryos(Three days after intra-cytoplasmic sperm injection)
- Number of good quality blastocysts(Five days after intra-cytoplasmic sperm injection)
- Implantation rate(At 3 weeks after embryo transfer after the completion of the embryo transfer)
- Ectopic pregnancy rate(3 weeks after embryo transfer)
- Very low birth weight rate(At birth)
- Number of MII oocytes(Two day after oocyte retrieval)
- Number of frozen day-3 embryos(Three days after ICSI)
- Number of blastocyst (day 5 or day 6 embryo)(Five or six days after ICSI)
- Number of frozen blastocysts(Three days after ICSI)
- Clinical pregnancy rate(5 weeks after embryo transfer)
- Gestational age at birth(At birth)
- Number of patients with no oocyte retrieved(On the day of oocyte retrieval)
- Number of good quality Day-3 embryos(Three days after intra-cytoplasmic sperm injection)
- Number of patients with no blastocyst(Five or six days after ICSI)
- Quality of embryos transferred (Grade 1, Grade 2, Grade 3)(On the day of embryo transfer)
- Positive pregnancy test rate(11 days after the day of blastocyst transfer and 13 days after the day of day-3 embryo transfer)
- Mode of delivery(At birth)
- Low birth weight rate(At birth)
- Very high birth weight rate(At birth)
- Reason for NICU admission(At birth)
- Number of embryos transferred(On the day of embryo transfer)
- Ongoing pregnancy rate(10 weeks after embryo transfer)
- Miscarriage <12 weeks rate (Early miscarriage)(2-10 weeks after embryo transfer)
- High birth weight rate(At birth)
- Gestational diabetes mellitus rate(At 24 to 28 weeks of gestation)
- Premature birth rate(On the day of delivery)
- NICU admission rate(At birth)
- Live birth rate(At 22 weeks of gestation)
- Still birth rate(After 20 completed weeks of gestational age)
- Neonatal mortality rate(between eight and 28 days after delivery)
- Multiple delivery rate(At 22 weeks' gestation)
- Major congenital abnormalities rate(At birth)
- Hypertension in pregnancy rate(At 20 weeks of gestation or beyond)
- Antepartum haemorrhage rate(At birth)
